查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612999

臨床診斷市場：按測試類型、適應症和最終用戶分類 - 全球預測 2025-2030

Clinical Laboratory Tests Market by Test Type (Basic Metabolic Panel, Complete Blood Count, Comprehensive Metabolic Panel), Indication (Autoimmune Diseases, Cardiovascular Diseases, Genetic Disorders), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年臨床診斷試劑市值為1,357.2億美元，預計2024年將達到1,453.1億美元，複合年成長率為7.27%，到2030年將達到2,218.6億美元。

臨床診斷市場的範圍包括在醫學實驗室進行的各種診斷和監測測試，以評估患者的健康狀況並協助檢測和預防疾病。這些測試包括常規血液測試、基因測試和專門的病理學測試。這些測試的需要是在及時診斷、治療評估、健康監測以及支持醫療保健提供者的臨床決策方面發揮重要作用。應用程式涵蓋醫院、診所、診斷實驗室和研究機構，最終用戶包括尋求準確健康見解的醫療保健專業人員和患者。市場成長主要受到慢性病盛行率上升、人口老化以及對疾病早期檢測的需求不斷增加的影響。個人化醫療、自動化以及人工智慧和巨量資料分析等技術創新的進步帶來了巨大的商機。為了利用這些機會，公司應該專注於開發方便用戶使用且具有成本效益的測試解決方案，並擴展到新興市場。然而，監管合規問題、高昂的測試成本以及生物醫學資料的複雜性給市場成長帶來了挑戰。人們也擔心某些新診斷技術的可靠性。該業務預計成長的創新領域包括就地檢驗、家庭檢測套組和用於安全高效資料管理的區塊鏈整合。此外，投資研發以開發基於生物標記的測試可以滿足精準醫療的需求。市場競爭格局的特徵是快速的技術進步和主要企業之間的策略聯盟。總體而言，市場的本質是動態和競爭的，不斷的創新為成長和差異化指明了道路。保持靈活性並了解監管趨勢和技術變革對於相關人員保持相關性和有效競爭至關重要。

主要市場統計
基準年[2023] 1357.2億美元
預計年份 [2024] 1453.1億美元
預測年份 [2030] 2218.6億美元
複合年成長率（%） 7.27%

市場動態：快速發展的臨床診斷市場的關鍵市場洞察

供需的動態交互作用正在改變臨床診斷試劑市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病增加
    • 全球醫療保健支出增加
    • 對個人化醫療的偏好日益成長
  • 市場限制因素
    • 臨床檢測試劑高成本
  • 市場機會
    • 對就地檢驗的需求不斷成長
    • 整合數位解決方案和臨床實驗室測試
  • 市場挑戰
    • 嚴格的臨床測試法律規範

波特五力：駕馭臨床試驗藥物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對臨床診斷藥物市場的影響

外部宏觀環境因素對臨床診斷試劑市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解臨床診斷試劑市場競爭狀況

對臨床診斷試劑市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣臨床診斷市場供應商績效評估

FPNV定位矩陣是評估臨床診斷市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議 繪製臨床測試試劑市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，臨床診斷試劑市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病增加
      • 世界各地的醫療費用增加
      • 對個人化醫療的興趣日益濃厚
    • 抑制因素
      • 臨床檢測試劑高成本
    • 機會
      • 就地檢驗的需求不斷增加
      • 整合數位解決方案和臨床測試
    • 任務
      • 嚴格的臨床測試法規結構
  • 市場區隔分析
    • 測試類型：綜合代謝面板擴大用於提供更觀點的基本代謝資訊。
    • 適應症：由於預測分析和精準醫學的重要性日益增加，遺傳疾病檢測取得了進展
    • 最終用戶：由於範圍更廣和成本效率更高，對獨立實驗室的偏好日益增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章按測試類型分類的臨床診斷藥物市場

  • 基礎代謝組
    • 鈣
    • 電解質
    • 葡萄糖
    • 腎臟測試
  • 全血細胞計數
  • 綜合代謝組
    • 肝臟測試
    • 蛋白質
  • 血脂譜
  • 甲狀腺檢查
  • 尿液檢查

第7章 臨床診斷藥物適應症市場

  • 自體免疫疾病
  • 心血管疾病
  • 遺傳疾病
  • 感染疾病
  • 腫瘤性疾病

第8章臨床診斷藥物市場：依最終使用者分類

  • 院內實驗室
  • 獨立研究所

第9章 北美、南美臨床診斷試劑市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太臨床診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲臨床診斷試劑市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Labcorp 從 OPKO Health 收購 BioReference Health 的關鍵資產，並在全國擴展臨床和生殖健康服務
    • KeyProteo 建立新的早期遺傳疾病篩檢實驗室，以改善新生兒護理
    • BSI 與 Nelson Labs 合作簡化 PPE 供應鏈並簡化全球監管流程
    • OnQuest Laboratories 與 Shruti Clinical Laboratories 合作增強孟買的先進檢測服務
    • Redcliffe Labs 收購 Medicenter，以加強南拉賈斯坦邦的市場影響並推動全國成長
    • Quest Diagnostics 透過收購北極光實驗室的主要資產加強緬因州醫療保健
  • 戰略分析和建議

公司名單

  • Apollo Health and Lifestyle Limited
  • Arup Laboratories Inc.
  • Bioscientia Healthcare GmbH
  • Biosino Bio-technology and Science Inc.
  • Charles River Laboratories, Inc
  • Cinven Ltd.
  • Clinical Reference Laboratory, Inc.
  • DaVita Inc. by UnitedHealth Group Inc.
  • Dr Lal PathLabs Pvt. Ltd
  • Eurofins Scientific SE
  • Fresenius Medical Care Holdings, Inc.
  • Laboratory Corporation of America Holdings
  • LifeLabs
  • Merck KgaA
  • Metropolis Health Products Retail Pvt Ltd.
  • Metropolis Healthcare
  • Novartis International AG
  • OPKO Health, Inc.
  • PerkinElmer, Inc.
  • Qiagen .NV
  • Quest Diagnostics Incorporated
  • Siemens Healthineers AG
  • Sonic Healthcare Limited
  • SYNLAB Group
  • Thermo Fisher Scientific Inc.
Product Code: MRR-A339DAEFAC71

The Clinical Laboratory Tests Market was valued at USD 135.72 billion in 2023, expected to reach USD 145.31 billion in 2024, and is projected to grow at a CAGR of 7.27%, to USD 221.86 billion by 2030.

The scope of the clinical laboratory tests market encompasses various diagnostic and monitoring tests conducted in medical laboratories to evaluate patient health and aid in disease detection and prevention. These tests include routine blood tests, genetic testing, and specialized pathology assays. The necessity of these tests is driven by their crucial role in timely diagnosis, treatment evaluation, and health monitoring, supporting healthcare providers in clinical decision-making. Their application extends to hospitals, clinics, diagnostic labs, and research institutes, with end-users including healthcare professionals and patients seeking accurate health insights. Market growth is primarily influenced by rising prevalence of chronic diseases, an aging population, and increasing demand for early disease detection. Advances in personalized medicine and technological innovations like automation and integration of AI and big data analytics present significant opportunities. Companies should focus on developing user-friendly, cost-effective testing solutions and expanding into emerging markets to leverage these opportunities. However, market growth is challenged by regulatory compliance issues, high testing costs, and the complexity of biomedical data. There is also apprehension regarding the reliability of certain novel diagnostic technologies. Innovation areas promising business growth include point-of-care testing, home testing kits, and the integration of blockchain for secure and efficient data management. Furthermore, investing in R&D for developing biomarker-based testing can meet the demand for precision medicine. The competitive landscape of the market is characterized by rapid technological advancements and strategic collaborations between key players. Overall, the market nature is dynamic and competitive, with ongoing innovations presenting avenues for growth and differentiation. It is critical for stakeholders to stay agile and informed on regulatory trends and technological shifts to maintain relevance and compete effectively.

KEY MARKET STATISTICS
Base Year [2023] USD 135.72 billion
Estimated Year [2024] USD 145.31 billion
Forecast Year [2030] USD 221.86 billion
CAGR (%) 7.27%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Clinical Laboratory Tests Market

The Clinical Laboratory Tests Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases
    • Growing healthcare expenditure globally
    • Rising preference for personalized medicine
  • Market Restraints
    • High cost associated with clinical laboratory tests
  • Market Opportunities
    • Growing need for point-of-care testing
    • Integration of digital solutions with clinical laboratory testing
  • Market Challenges
    • Stringent regulatory frameworks for clinical laboratory test

Porter's Five Forces: A Strategic Tool for Navigating the Clinical Laboratory Tests Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Clinical Laboratory Tests Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Clinical Laboratory Tests Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Clinical Laboratory Tests Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Clinical Laboratory Tests Market

A detailed market share analysis in the Clinical Laboratory Tests Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Clinical Laboratory Tests Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Clinical Laboratory Tests Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Clinical Laboratory Tests Market

A strategic analysis of the Clinical Laboratory Tests Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Clinical Laboratory Tests Market, highlighting leading vendors and their innovative profiles. These include Apollo Health and Lifestyle Limited, Arup Laboratories Inc., Bioscientia Healthcare GmbH, Biosino Bio-technology and Science Inc., Charles River Laboratories, Inc, Cinven Ltd., Clinical Reference Laboratory, Inc., DaVita Inc. by UnitedHealth Group Inc., Dr Lal PathLabs Pvt. Ltd, Eurofins Scientific SE, Fresenius Medical Care Holdings, Inc., Laboratory Corporation of America Holdings, LifeLabs, Merck KgaA, Metropolis Health Products Retail Pvt Ltd., Metropolis Healthcare, Novartis International AG, OPKO Health, Inc., PerkinElmer, Inc., Qiagen .N.V., Quest Diagnostics Incorporated, Siemens Healthineers AG, Sonic Healthcare Limited, SYNLAB Group, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Clinical Laboratory Tests Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Test Type, market is studied across Basic Metabolic Panel, Complete Blood Count, Comprehensive Metabolic Panel, Lipid Profile, Thyroid Test, and Urinalysis. The Basic Metabolic Panel is further studied across Calcium, Electrolytes, Glucose, and Kidney Tests. The Comprehensive Metabolic Panel is further studied across Liver Tests and Proteins.
  • Based on Indication, market is studied across Autoimmune Diseases, Cardiovascular Diseases, Genetic Disorders, Infectious Diseases, and Oncological Diseases.
  • Based on End-User, market is studied across Hospital-Based Laboratories and Independent Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases
      • 5.1.1.2. Growing healthcare expenditure globally
      • 5.1.1.3. Rising preference for personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with clinical laboratory tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing need for point-of-care testing
      • 5.1.3.2. Integration of digital solutions with clinical laboratory testing
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory frameworks for clinical laboratory test
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Test Type: Growing utilization of comprehensive metabolic panel as provides foundational metabolic information with more comprehensive view
    • 5.2.2. Indication: Advancements in the genetic disorder testing with growing significance of predictive analytics and precision medicine
    • 5.2.3. End-User: Increasing preference for independent laboratories due to its broader reach and cost-effectivity
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Laboratory Tests Market, by Test Type

  • 6.1. Introduction
  • 6.2. Basic Metabolic Panel
    • 6.2.1. Calcium
    • 6.2.2. Electrolytes
    • 6.2.3. Glucose
    • 6.2.4. Kidney Tests
  • 6.3. Complete Blood Count
  • 6.4. Comprehensive Metabolic Panel
    • 6.4.1. Liver Tests
    • 6.4.2. Proteins
  • 6.5. Lipid Profile
  • 6.6. Thyroid Test
  • 6.7. Urinalysis

7. Clinical Laboratory Tests Market, by Indication

  • 7.1. Introduction
  • 7.2. Autoimmune Diseases
  • 7.3. Cardiovascular Diseases
  • 7.4. Genetic Disorders
  • 7.5. Infectious Diseases
  • 7.6. Oncological Diseases

8. Clinical Laboratory Tests Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospital-Based Laboratories
  • 8.3. Independent Laboratories

9. Americas Clinical Laboratory Tests Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Clinical Laboratory Tests Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Clinical Laboratory Tests Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Labcorp to Acquire Key BioReference Health Assets from OPKO Health, Expanding Clinical and Reproductive Health Services Nationwide
    • 12.3.2. Key Proteo Advances Newborn Care with New Laboratory for Early Genetic Disorder Screening
    • 12.3.3. BSI Teams Up with Nelson Labs to Streamline PPE Supply Chains and Simplify Global Regulatory Processes
    • 12.3.4. Oncquest Laboratories Partners with Shruti Clinical Laboratory to Boost Advanced Testing Services in Mumbai
    • 12.3.5. Redcliffe Labs Acquires Medicentre, Strengthening Market Presence in Southern Rajasthan and Advancing Nationwide Growth
    • 12.3.6. Quest Diagnostics Enhances Maine Healthcare with Key Asset Acquisition from Northern Light Laboratory
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Apollo Health and Lifestyle Limited
  • 2. Arup Laboratories Inc.
  • 3. Bioscientia Healthcare GmbH
  • 4. Biosino Bio-technology and Science Inc.
  • 5. Charles River Laboratories, Inc
  • 6. Cinven Ltd.
  • 7. Clinical Reference Laboratory, Inc.
  • 8. DaVita Inc. by UnitedHealth Group Inc.
  • 9. Dr Lal PathLabs Pvt. Ltd
  • 10. Eurofins Scientific SE
  • 11. Fresenius Medical Care Holdings, Inc.
  • 12. Laboratory Corporation of America Holdings
  • 13. LifeLabs
  • 14. Merck KgaA
  • 15. Metropolis Health Products Retail Pvt Ltd.
  • 16. Metropolis Healthcare
  • 17. Novartis International AG
  • 18. OPKO Health, Inc.
  • 19. PerkinElmer, Inc.
  • 20. Qiagen .N.V.
  • 21. Quest Diagnostics Incorporated
  • 22. Siemens Healthineers AG
  • 23. Sonic Healthcare Limited
  • 24. SYNLAB Group
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. CLINICAL LABORATORY TESTS MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL LABORATORY TESTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CLINICAL LABORATORY TESTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CLINICAL LABORATORY TESTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL LABORATORY TESTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL LABORATORY TESTS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CALCIUM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ELECTROLYTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GLUCOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY KIDNEY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIVER TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY THYROID TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY ONCOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY HOSPITAL-BASED LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CLINICAL LABORATORY TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY BASIC METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM CLINICAL LABORATORY TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. CLINICAL LABORATORY TESTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. CLINICAL LABORATORY TESTS MARKET, FPNV POSITIONING MATRIX, 2023